Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Administration

This study retrospectively reviewed the outcomes of patients with advanced hepatocellular carcinoma (HCC) receiving atezolizumab with bevacizumab (A + B) therapy at the Veterans Health Administration (VHA). Patients with advanced HCC who received first-line systemic therapy with A + B at the VHA bet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2024-05, Vol.29 (5), p.369-376
Hauptverfasser:	Alkadimi, Munaf A, Aldawoodi, Tamarah A, Lucero, Kana T, Fierro, Maria E, Boyle, Lauren D, Mader, Michael J, Franklin, Kathleen R, Arora, Sukeshi P, Nooruddin, Zohra
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - therapeutic use Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Demographic aspects Drug therapy Female Hepatoma Humans Liver Neoplasms - drug therapy Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - therapy Male Middle Aged Patient outcomes Retrospective Studies Treatment Outcome United States - epidemiology United States Department of Veterans Affairs - statistics & numerical data Veterans Health - statistics & numerical data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!